sotorasib
amgen,mirati
['lumakras', 'codebreak-200', '$amgn', '$mrtx']
#esmo22's final shocker. $amgn kras late-breaker for codebreak-200 lumakras confirmatory trial: no os benefit
7.7% gr3+ liver enzyme elevations
(pfs hr=0.66, p=0.002) advantage $mrtx? 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.